0000805928-25-000072.txt : 20250523 0000805928-25-000072.hdr.sgml : 20250523 20250523163240 ACCESSION NUMBER: 0000805928-25-000072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250522 FILED AS OF DATE: 20250523 DATE AS OF CHANGE: 20250523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TYNDALL JOSEPH A. CENTRAL INDEX KEY: 0001955281 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36046 FILM NUMBER: 25982941 MAIL ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axogen, Inc. CENTRAL INDEX KEY: 0000805928 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 411301878 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: (386) 462-6817 MAIL ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 FORMER COMPANY: FORMER CONFORMED NAME: AxoGen, Inc. DATE OF NAME CHANGE: 20111004 FORMER COMPANY: FORMER CONFORMED NAME: LECTEC CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 wk-form4_1748032349.xml FORM 4 X0508 4 2025-05-22 0 0000805928 Axogen, Inc. AXGN 0001955281 TYNDALL JOSEPH A. C/O AXOGEN, INC. 13631 PROGRESS BLVD., SUITE 400 ALACHUA FL 32615 1 0 0 0 0 Common Stock 2025-05-22 4 M 0 12850 6.30 A 35407 D Common Stock 2025-05-22 4 S 0 12850 11.20 D 22557 D Common Stock 2025-05-22 4 S 0 7212 11.20 D 15345 D Stock Option (right to purchase) 6.30 2025-05-22 4 M 0 12850 6.30 D 2033-09-01 Common Stock 12850 7586 D The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions at prices ranging from $11.15 to $11.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions at prices ranging from $11.15 to $11.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Options vested on the first anniversary of the grant date, which was September 1, 2023. /s/ Marc Began as attorny-in-fact for Joseph A. Tyndall 2025-05-23